By Type
Misleading Marketing Tactics Results in Consumers Being Steered Away from the Federal Marketplace
A 2021 study by Georgetown University Health Policy Institute Center found that during the COVID-19 special enrollment period online enrollment…
Aimed Alliance Releases 2020 Annual Report
In 2020, Aimed Alliance engaged in a wide array of activities to protect and enhance the rights of health care…
UPCOMING WEBINAR MARCH 29: Change Is Law – A Federal Drug Policy Update
The federal government’s COVID-19 public health emergency (PHE) declaration will end on May 11, 2023. The drug poisoning PHE, first…
Digital Therapeutics: What They Are and How to Integrate Them in Addiction Treatment Workflows
This session will focus on the emerging role of digital therapeutics (DTx) in the treatment of substance use disorders (SUDs),…
Aimed Alliance Urges Senators to Expand Access to Treatments for OUD
On November 2, 2022, Aimed Alliance hosted a legislative briefing on facilitating access to medications for opioid use disorders (“MOUD”).…
Aimed Alliance Releases Updated Open Enrollment Brochures
The open enrollment periods for individual, small, large group, and Medicare plans have recently opened for 2023 enrollment! To ensure…
Share Your Experience: Treatment Access & Your Mental Health Care
Alliance for Mental Health Care Access Survey The Alliance for Mental Health Care Access (AMHCA) is excited to share a…
New Aimed Alliance Infographic Identifies Best Practices for Migraine Management in the Workplace
A new Aimed Alliance infographic demonstrates ongoing challenges employees with migraine disease face in the workplace and best practices employers…
Aimed Alliance Releases 2022 Annual Impact Report
In 2022, Aimed Alliance engaged in a wide variety of activities to protect and enhance the rights of health care…
Available Now: Essential Health Benefits, Importation, and More — Do You Know the Risks?
On December 13, Aimed Alliance hosted a webinar on HR.com title “Essential Health Benefits, Importation, and More — Do You…
